Cargando…
Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1
Doxorubicin is used extensively for chemotherapy of diverse types of cancer, yet the mechanism through which it inhibits proliferation of cancer cells remains unclear. Here we report that doxorubicin stimulates de novo synthesis of ceramide, which in turn activates CREB3L1, a transcription factor sy...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524649/ https://www.ncbi.nlm.nih.gov/pubmed/23256041 http://dx.doi.org/10.7554/eLife.00090 |
_version_ | 1782253345269874688 |
---|---|
author | Denard, Bray Lee, Ching Ye, Jin |
author_facet | Denard, Bray Lee, Ching Ye, Jin |
author_sort | Denard, Bray |
collection | PubMed |
description | Doxorubicin is used extensively for chemotherapy of diverse types of cancer, yet the mechanism through which it inhibits proliferation of cancer cells remains unclear. Here we report that doxorubicin stimulates de novo synthesis of ceramide, which in turn activates CREB3L1, a transcription factor synthesized as a membrane-bound precursor. Doxorubicin stimulates proteolytic cleavage of CREB3L1 by Site-1 Protease and Site-2 Protease, allowing the NH(2)-terminal domain of CREB3L1 to enter the nucleus where it activates transcription of genes encoding inhibitors of the cell cycle, including p21. Knockdown of CREB3L1 mRNA in human hepatoma Huh7 cells and immortalized human fibroblast SV589 cells conferred increased resistance to doxorubicin, whereas overexpression of CREB3L1 in human breast cancer MCF-7 cells markedly enhanced the sensitivity of these cells to doxorubicin. These results suggest that measurement of CREB3L1 expression may be a useful biomarker in identifying cancer cells sensitive to doxorubicin. DOI: http://dx.doi.org/10.7554/eLife.00090.001 |
format | Online Article Text |
id | pubmed-3524649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-35246492012-12-19 Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1 Denard, Bray Lee, Ching Ye, Jin eLife Biochemistry Doxorubicin is used extensively for chemotherapy of diverse types of cancer, yet the mechanism through which it inhibits proliferation of cancer cells remains unclear. Here we report that doxorubicin stimulates de novo synthesis of ceramide, which in turn activates CREB3L1, a transcription factor synthesized as a membrane-bound precursor. Doxorubicin stimulates proteolytic cleavage of CREB3L1 by Site-1 Protease and Site-2 Protease, allowing the NH(2)-terminal domain of CREB3L1 to enter the nucleus where it activates transcription of genes encoding inhibitors of the cell cycle, including p21. Knockdown of CREB3L1 mRNA in human hepatoma Huh7 cells and immortalized human fibroblast SV589 cells conferred increased resistance to doxorubicin, whereas overexpression of CREB3L1 in human breast cancer MCF-7 cells markedly enhanced the sensitivity of these cells to doxorubicin. These results suggest that measurement of CREB3L1 expression may be a useful biomarker in identifying cancer cells sensitive to doxorubicin. DOI: http://dx.doi.org/10.7554/eLife.00090.001 eLife Sciences Publications, Ltd 2012-12-18 /pmc/articles/PMC3524649/ /pubmed/23256041 http://dx.doi.org/10.7554/eLife.00090 Text en Copyright © 2012, Denard et al http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Biochemistry Denard, Bray Lee, Ching Ye, Jin Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1 |
title | Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1 |
title_full | Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1 |
title_fullStr | Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1 |
title_full_unstemmed | Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1 |
title_short | Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1 |
title_sort | doxorubicin blocks proliferation of cancer cells through proteolytic activation of creb3l1 |
topic | Biochemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524649/ https://www.ncbi.nlm.nih.gov/pubmed/23256041 http://dx.doi.org/10.7554/eLife.00090 |
work_keys_str_mv | AT denardbray doxorubicinblocksproliferationofcancercellsthroughproteolyticactivationofcreb3l1 AT leeching doxorubicinblocksproliferationofcancercellsthroughproteolyticactivationofcreb3l1 AT yejin doxorubicinblocksproliferationofcancercellsthroughproteolyticactivationofcreb3l1 |